Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Clinical Trial to Evaluate the Clinical Value and Cost-effectiveness of a Personalized Prevention Program in Patients With High Risk Stable Coronary Heart Disease

NCT04433052 is registered in ClinicalTrials.gov with Tampere University as lead sponsor.

NCT NCT04433052
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04433052 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Clinical Trial to Evaluate the Clinical Value and Cost-effectiveness of a Personalized Prevention Program in Patients With High Risk Stable Coronary Heart Disease
Lead sponsor
Tampere University
Phase
Not applicable
Overall status
Recruiting
Start date
February 1, 2023
Completion date
December 31, 2026
Enrollment
12,000 (estimated)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

coronary heart disease